“…In preclinical back pain models, signs of inflammation include invasion of the DRG by immune cells, activation of the satellite glia, upregulation of pro-inflammatory cytokines, and downregulation of anti-inflammatory cytokines (Kawakami et al, 1996;Murata et al, 2006b;Xie et al, 2006;Sasaki et al, 2007;Amaya et al, 2009;Otoshi et al, 2010;Huang et al, 2011;Watanabe et al, 2011;de Souza Grava et al, 2012). However, DRG inflammation also plays a role in neuropathic pain models that involve axon damage or transection, especially during the early phase.…”